Rubrik (NYSE: RBRK) expands AI cybersecurity alliance as Code Guardian enters enterprise delivery push
Read More Pharma Industry News Median Technologies secures €37.5m EIB funding to advance eyonis AI cancer diagnostics and US launch Median Technologies secures €37.5M from the European Investment Bank to accelerate AI-driven eyonis® cancer screening software commercialization in the US and EU. byPallavi MadhirajuJuly 14, 2025